| 000 | 02022pam a2200445 i 4500 | ||
|---|---|---|---|
| 999 |
_c12740 _d12740 |
||
| 001 | 740715 | ||
| 005 | 20210302142811.0 | ||
| 008 | 990301s1999 dcu b 001 0 eng c | ||
| 010 | _a 99020308 | ||
| 020 | _a0917330951 (hbk.) | ||
| 040 |
_aDNLM/DLC _cDLC _dDLC _erda |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRS189.5.H54 _bX8 1999 |
| 060 | 1 | 0 |
_aQV 25 _bX8s 1999 |
| 082 | 0 | 0 |
_a615.1901 _222 _bX.Q.S |
| 100 | 1 |
_aXu, Quanyun A., _d1961-, _eauthor. |
|
| 245 | 0 | 0 |
_aStability-indicating HPLC methods for drug analysis / _cQuanyun A. Xu, PhD, researcher scientist, clinical pharmaceutics research program, division of pharmacy, University of Texas M.D. Anderson cancer center, Houston, Texas, Lawrence A. Trissel, FASHP, Director, clinical pharmaceutics research program, division of pharmacy, University of Texas M.D. Anderson cancer center, Houston, Texas |
| 246 | 3 | _aStability indicating HPLC methods for drug analysis | |
| 260 | _cc1999. | ||
| 264 | 1 |
_aWashington, D.C. : _bAmerican Pharmaceutical Association ; _aLondon, England : _bPharmaceutical Press, _c[1999] |
|
| 264 | 4 | _c©1999 | |
| 300 |
_axiv, 391 pages ; _c26 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aDrugs _xAnalysis. |
|
| 650 | 0 | _aHigh performance liquid chromatography. | |
| 650 | 0 | _aDrug stability. | |
| 650 | 2 | 2 |
_aChromatography, High Pressure Liquid _xmethods. |
| 650 | 2 | 2 | _aDrug Stability. |
| 650 | 1 | 2 |
_aPharmaceutical Preparations _xanalysis. |
| 700 | 1 |
_aTrissel, Lawrence A. _eauthor. |
|
| 856 | 4 | 1 |
_3Table of contents _uhttp://www.loc.gov/catdir/toc/mh031/99020308.html |
| 856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/description/mh031/99020308.html |
| 906 |
_a7 _bcbc _cpccadap _d1 _eocip _f19 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||